A Two-Step Protocol for Isolation and Maintenance of Lung Cancer Primary 3D Cultures DOI Open Access
Silvia Strocchi, Giacomo Santandrea, Eleonora Zanetti

et al.

Cancers, Journal Year: 2024, Volume and Issue: 17(1), P. 27 - 27

Published: Dec. 25, 2024

Background/Objectives: Despite the introduction of innovative therapeutics, lung cancer is still leading cause cancer-related death. For this reason, requires deep characterization to identify cellular and molecular targets that can be used develop novel therapeutic strategies. Three-dimensional models, including patient-derived organoids (PDOs), represent useful tools study biology may employed in future as predictive decisions. However, successful establishment cultures faithfully respective patient tissues challenging due low success rate and/or overgrowth normal airway epithelial cells. Methods: We set up a two-step protocol allows for establishing both short-term long-term 3D cultures, with different characteristics rates. Results: Cancer tissue-originated spheroids (CTOSs) show 100% allow concomitant isolation autologous tumor infiltrating leukocytes (TILs). On contrary, PDOs expanded medium-long term bio-banked but retain lower possibility contamination To overcome these problems, we an optimal medium formulation implemented rigorous quality controls, substantial improvement tumoral PDO establishment. Conclusions: Overall, guarantees flexibility reliability, also providing guidelines control checks support experimental settings. The setting robust culture expansion key requirement their employment research clinical practice.

Language: Английский

Drug-induced senescence by aurora kinase inhibitors attenuates innate immune response of macrophages on gastric cancer organoids DOI Creative Commons
Ruixin Yang,

Wingyan Kwan,

Yutong Du

et al.

Cancer Letters, Journal Year: 2024, Volume and Issue: 598, P. 217106 - 217106

Published: July 9, 2024

Diffuse-type gastric cancer (DGC) is a subtype of with aggressiveness and poor prognosis. It great significance to find sensitive drugs for DGC. In the current study, total 20 patient-derived organoids (PDOs) were analyzed screening therapeutic efficacy small molecule kinases inhibitors on cancers, especially difference between intestinal-type (IGCs) DGCs. The IGCs are multiple inhibitors, while DGCs resistant most these inhibitors. was found that showed drug-induced senescent phenotype after treatment by aurora (AURKi) Barasertib-HQPA Danusertib. cell diameter cells increased stronger staining senescence-associated β-galactosidase (SA-β-GAL), characteristic appearance multinucleated giant cells. secrete large amounts chemokine MCP-1/CCL2, which recruit induce macrophage M2-type polarization in PDOs DGC (DPDOs)-macrophage co-culture system. up-regulation local MCP-1/CCL2 can interact receptor (CCR2) expressed macrophages suppress their innate immunity Overall, special response AURKi suggests clinicians should select sequential therapy clearance

Language: Английский

Citations

6

Constructing Tumor Organoid-like Tissue for Reliable Drug Screening Using Liver-Decellularized Extracellular Matrix Scaffolds DOI Creative Commons
Zhoujiang Chen,

Lianlin Long,

Ji Wang

et al.

ACS Omega, Journal Year: 2024, Volume and Issue: unknown

Published: Jan. 29, 2024

The interplay between cells and their microenvironments plays a pivotal role in

Language: Английский

Citations

5

The Evolution of Technology‐Driven In Vitro Models for Neurodegenerative Diseases DOI Creative Commons
Eleonora De Vitis,

Antonella Stanzione,

Alessandro Romano

et al.

Advanced Science, Journal Year: 2024, Volume and Issue: 11(16)

Published: Feb. 17, 2024

Abstract The alteration in the neural circuits of both central and peripheral nervous systems is closely related to onset neurodegenerative disorders (NDDs). Despite significant research efforts, knowledge regarding NDD pathological processes, development efficacious drugs are still limited due inability access reproduce components system its intricate microenvironment. 2D culture too simplistic accurately represent more complex dynamic situation cells vivo have therefore been surpassed by 3D systems. However, models suffer from various limitations that can be overcome employing two innovative technologies: organ‐on‐chip printing. In this review, an overview advantages shortcomings microfluidic platforms extracellular matrix‐like biomaterials will given. Then, combination microfluidics hydrogels as a new synergistic approach study analyzing latest advances brain‐on‐chip for explored.

Language: Английский

Citations

5

Precision Medicine for Peritoneal Carcinomatosis—Current Advances in Organoid Drug Testing and Clinical Applicability DOI Creative Commons

Harleen Kaur,

Josephine A. Wright, Daniel L. Worthley

et al.

Organoids, Journal Year: 2025, Volume and Issue: 4(1), P. 2 - 2

Published: Jan. 24, 2025

Peritoneal carcinomatosis from gastrointestinal tumours is considered a poor prognostic factor, with median overall survival of six to nine months in the absence intervention. The advent patient-derived organoid cultures (PDOs) has provided breakthrough personalised medicine, allowing researchers and clinicians model complexity heterogeneity individual vitro. PDOs hold great promise this field, as variations management peritoneal due differences method delivery chemotherapeutics, drug selection, exposure duration, tumour pathology make it impractical use single, standardised treatment regimen. We aim summarise methodologies limitations studies encapsulating organoids derived metastases encourage design considerations that may improve future clinical relevance, standardise protocols, address translational challenges personalising strategies.

Language: Английский

Citations

0

“ Advancing Nephrogenetics: Utilizing Single-Cell RNA Sequencing and Organoid Models for Precision Kidney Disease Treatment” DOI

Mohanapriya C.D.,

Praveen Kumar Kochuthakidiyel Suresh

Current Pediatrics Reports, Journal Year: 2025, Volume and Issue: 13(1)

Published: March 17, 2025

Language: Английский

Citations

0

Insights into targeting cellular senescence with senolytic therapy: The journey from preclinical trials to clinical practice DOI
Peng Chen,

Yulai Wang,

Benhong Zhou

et al.

Mechanisms of Ageing and Development, Journal Year: 2024, Volume and Issue: 218, P. 111918 - 111918

Published: Feb. 23, 2024

Language: Английский

Citations

3

Interleukin 13 Promotes Maturation and Proliferation in Metaplastic Gastroids DOI Creative Commons

Ela W. Contreras-Panta,

Su-Hyung Lee,

Yoonkyung Won

et al.

Cellular and Molecular Gastroenterology and Hepatology, Journal Year: 2024, Volume and Issue: 18(3), P. 101366 - 101366

Published: Jan. 1, 2024

Type 2 innate lymphoid cells (ILC2s) and interleukin-13 (IL-13) promote the onset of spasmolytic polypeptide-expressing metaplasia (SPEM) cells. However, little is known about molecular effects IL-13 in SPEM We now sought to establish a reliable organoid model, Meta1 gastroids, model vitro. evaluated cellular ILC2s on maturation proliferation

Language: Английский

Citations

3

Current advances in understanding endometrial epithelial cell biology and therapeutic applications for intrauterine adhesion DOI Creative Commons
Jia Wang, Hong Zhan, Y Wang

et al.

Stem Cell Research & Therapy, Journal Year: 2024, Volume and Issue: 15(1)

Published: Oct. 25, 2024

The human endometrium is a highly regenerative tissue capable of undergoing scarless repair during the menstruation and postpartum phases. This process mediated by endometrial adult stem/progenitor cells. During healing injuries, swift reepithelization results in rapid covering wound surface facilitates subsequent restoration. involvement endogenous epithelial stem cells, stromal bone marrow-derived cells regeneration epithelium has been subject prolonged debate. Increasing evidence suggests that mainly relies on rather than Currently, no consensus established identity compartment. Several markers, including stage-specific embryonic antigen-1 (SSEA-1), sex-determining region Y-box 9 (SOX9), neural-cadherin (N-cadherin), leucine-rich-repeat-containing G-protein-coupled receptor 5 (LGR5), CD44, axis inhibition protein 2 (Axin2), aldehyde dehydrogenase 1A1 (ALDH1A1), have suggested as potential candidate markers for identification contributes to our understanding offers new therapeutic insights into diseases characterized defects endometrium, such intrauterine adhesion. review explores different perspectives origins mouse It summarizes locations, hierarchies both endometrium. also discusses cell-based treatments adhesion, hoping inspire further research clinical application

Language: Английский

Citations

2

New Therapeutic Perspectives in Prostate Cancer: Patient-Derived Organoids and Patient-Derived Xenograft Models in Precision Medicine DOI Creative Commons
Vittoria Rago, Anna Perri, Silvia Di Agostino

et al.

Biomedicines, Journal Year: 2023, Volume and Issue: 11(10), P. 2743 - 2743

Published: Oct. 10, 2023

One of the major goals in advancement basic cancer research focuses on development new anticancer therapies. To understand molecular mechanisms progression, acquired drug resistance, and metastatic process, use preclinical vitro models that faithfully summarize properties tumor patients is still a necessity. The represented by diverse group cell clones, recent years, to reproduce models, monolayer cultures have been supplanted patient-derived xenograft (PDX) cultured organoids derived from patient (PDO). These proved indispensable for study microenvironment (TME) its interaction with cells. Prostate (PCa) most common neoplasia men world. It characterized genomic instability resistance conventional Despite advances diagnosis treatment, PCa remains leading cause death. Here, we review studies last 10 years as number papers growing very fast field. We also discuss discovered limitations challenges using organoid culture system PDXs studying prostate phenotype, performing testing, developing

Language: Английский

Citations

4

Patient derived cancer organoids model the response to HER2-CD3 bispecific antibody (BsAbHER2) generated from hydroxyapatite gene delivery system DOI
Yuhong Liu, Chen Wang,

Guochuang Chen

et al.

Cancer Letters, Journal Year: 2024, Volume and Issue: 597, P. 217043 - 217043

Published: June 12, 2024

Language: Английский

Citations

1